Correlation Between Hudson Acquisition and Entheon Biomedical

Can any of the company-specific risk be diversified away by investing in both Hudson Acquisition and Entheon Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hudson Acquisition and Entheon Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hudson Acquisition I and Entheon Biomedical Corp, you can compare the effects of market volatilities on Hudson Acquisition and Entheon Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hudson Acquisition with a short position of Entheon Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hudson Acquisition and Entheon Biomedical.

Diversification Opportunities for Hudson Acquisition and Entheon Biomedical

0.0

Correlation Coefficient

Hudson Acquisition  Entheon Biomedical

Pay attention - limited upside

The 3 months correlation between Hudson and Entheon is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hudson Acquisition I and Entheon Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entheon Biomedical Corp and Hudson Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hudson Acquisition I are associated (or correlated) with Entheon Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entheon Biomedical Corp has no effect on the direction of Hudson Acquisition i.e., Hudson Acquisition and Entheon Biomedical go up and down completely randomly.

Pair Corralation between Hudson Acquisition and Entheon Biomedical

If you would invest  11.00  in Entheon Biomedical Corp on October 10, 2024 and sell it today you would earn a total of  9.00  from holding Entheon Biomedical Corp or generate 81.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Hudson Acquisition I  vs.  Entheon Biomedical Corp

Hudson Acquisition

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hudson Acquisition I has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Hudson Acquisition is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Entheon Biomedical Corp

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entheon Biomedical Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating fundamental drivers, Entheon Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Hudson Acquisition and Entheon Biomedical

The main advantage of trading using opposite Hudson Acquisition and Entheon Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hudson Acquisition position performs unexpectedly, Entheon Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entheon Biomedical will offset losses from the drop in Entheon Biomedical's long position.

The idea behind Hudson Acquisition I and Entheon Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.